VIM and cancer: Upon further molecular characterization for cancer hallmark biomarkers, with comparable results observed in the Oncopig pancreatic cancer model 22, we found downregulation of cell-cell adherens junction transmembrane protein E-cadherin and expression of EMT marker vimentin as indicators of metastatic capacity.